Danaparoid cross-reactivity with heparin-induced thrombocytopenia antibodies: report of 12 cases

Author： Tardy-Poncet B.   Wolf M.   Lasne D.   Bauters A.   Ffrench P.   Elalamy I.   Tardy B.  

Publisher： Springer Publishing Company

ISSN： 0342-4642

Source： Intensive Care Medicine, Vol.35, Iss.8, 2009-08, pp. : 1449-1453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ciprofloxacin‐induced immune‐mediated thrombocytopenia: No cross‐reactivity with gemifloxacin

By  

JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol. 43, Iss. 1, 2018-02 ,pp. : 134-136

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heparin-Induced Thrombocytopenia: Frequency and Pathogenesis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 35, Iss. 1-2, 2006-06 ,pp. : 37-45

Karger

Access to resources Recommend Favorite

Heparin‐induced thrombocytopenia: a cautionary tale

By  

TRANSFUSION, Vol. 55, Iss. 12, 2015-12 ,pp. : 2790-2790

John Wiley & Sons Inc

Access to resources Recommend Favorite

Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 1538-7933, Iss. 10, 2015-10 ,pp. : 1900-1907

John Wiley & Sons Inc

Access to resources Recommend Favorite

Protamine (heparin)‐induced thrombocytopenia: a review of the serological and clinical features associated with anti‐protamine/heparin antibodies

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 14, Iss. 9, 2016-09 ,pp. : 1685-1695

John Wiley & Sons Inc

Access to resources Recommend Favorite